Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Capital Expenditures (2021 - 2025)

Historic Capital Expenditures for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $499000.0.

  • Biote's Capital Expenditures fell 6780.65% to $499000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 531.83%. This contributed to the annual value of $6.4 million for FY2024, which is 17315.21% up from last year.
  • According to the latest figures from Q3 2025, Biote's Capital Expenditures is $499000.0, which was down 6780.65% from $1.8 million recorded in Q2 2025.
  • Biote's 5-year Capital Expenditures high stood at $2.5 million for Q2 2024, and its period low was $33000.0 during Q3 2023.
  • For the 5-year period, Biote's Capital Expenditures averaged around $915588.2, with its median value being $704000.0 (2024).
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 9147.29% in 2023, then soared by 459696.97% in 2024.
  • Quarter analysis of 5 years shows Biote's Capital Expenditures stood at $373000.0 in 2021, then dropped by 17.96% to $306000.0 in 2022, then soared by 280.07% to $1.2 million in 2023, then soared by 43.59% to $1.7 million in 2024, then tumbled by 70.12% to $499000.0 in 2025.
  • Its Capital Expenditures was $499000.0 in Q3 2025, compared to $1.8 million in Q2 2025 and $1.6 million in Q1 2025.